The UK is home to one of UCB's three global discovery research centres, a state-of-the art pre-manufacturing tech-ops scale up facility and our UK & Ireland commercial affiliate. Across the UK and Ireland, we employ around 850 people, the majority of whom are scientists working in R&D.

The COVID-19 pandemic has profoundly impacted lives and placed tremendous strain on our healthcare system and society.
Since the start of the crisis, UCB in the UK has taken measures to protect our colleagues and their families, our contractors and partners to support their health and wellbeing during these tough times. Doing this has helped us ensure a reliable supply of medicines for those patients who rely on us and has enabled us to offer support to others where we are can. We know that it is our responsibility to help where we can make an impact.
We have undertaken a Risk Assessment and continue to take every precaution to ensure a safe working environment which protects our colleagues, contractors and partners and will allow us to return to business as usual in a safe and timely way.

If you are visiting us on site please take a look at these principles which outline our joint responsibilities to minimise the risk of COVID-19 transmission.